Skip to main
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. reported total revenues of $307.0 million for the latest fiscal year, reflecting a year-over-year increase of approximately 5.9%, with notable growth in both licensing revenue (up 5.6%) and product/services revenue (up 10%). The company's operating margins improved to 33.2%, up from 31.2% in the previous fiscal year, indicating enhanced profitability amidst a challenging macroeconomic environment. Additionally, the expansion of its technologies, such as Dolby Vision, along with the shift towards SaaS-like models and increased adoption in key markets like China and India, further underscores the potential for sustained revenue growth and market position.

Bears say

Dolby Laboratories Inc. is facing a challenging outlook, reflected in management's revised growth expectations for its Atmos/Vision/Patents business, which are now set at 15% to 20% over the next 3 to 5 years, a decline from the previous forecast of 15% to 25%. The company anticipates a high-single-digit revenue decline for fiscal 2026, mirroring a similar trend from fiscal 2025, coupled with a decrease in gross margins to 89.7% from 90.1% year-over-year. Additionally, foundational revenues, primarily linked to device volumes, are expected to decrease by low-single digits, indicating ongoing headwinds from post-pandemic purchasing patterns.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Jan 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $92, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $92, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.